11/13/2020 9:07:21 AM
Qualigen Therapeutics Q2 Total Revenues $0.8 Mln Vs. $1.2 Mln Prior Year
10/28/2020 9:02:54 AM
Qualigen Receives Positive Pre-IND Response From FDA For Clinical Development Of AS1411 As Treatment For COVID-19
10/8/2020 9:04:56 AM
Qualigen Enters Into Commercialization Deal For Its FastPack Diagnostic Products In China
8/20/2020 8:05:12 AM
Qualigen Announces Issuance Of STARS Technology Patent By U.S. Patent And Trademark Office